Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Pfizer (PFE) Reports Top-Line Results of ABRYSVO for RSV in Immunocompromised Adults

Pfizer (PFE) PT Raised to $30 at Citi

August 13, 2024 4:41 PM EDT

Citi analyst Andrew Baum raised the price target on Pfizer (NYSE: PFE) to $30.00 (from $28.00) while maintaining a Neutral rating.

The analyst comments "We update our forecasts post 2Q24 to incorporate latest results and guidance, and sales, prescription, and currency trends. Our 2024E non-GAAP EPS... More